Cargando…
Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal A Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy with Epirubicin Plus Paclitaxel
BACKGROUND: The luminal A subtype of breast cancer has a good prognosis and is sensitive to endocrine therapy but is less sensitive to chemotherapy. It is necessary to identify biomarkers to predict chemosensitivity and avoid over-treatment. We hypothesized that miRNAs in the serum might be associat...
Autores principales: | Li, Qian, Liu, Mei, Ma, Fei, Luo, Yang, Cai, Ruigang, Wang, Liming, Xu, Ningzhi, Xu, Binghe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138038/ https://www.ncbi.nlm.nih.gov/pubmed/25137071 http://dx.doi.org/10.1371/journal.pone.0104870 |
Ejemplares similares
-
Correction: Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal A Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy with Epirubicin Plus Paclitaxel
por: Li, Qian, et al.
Publicado: (2015) -
Association between Lymph Node Status and Expression Levels of Androgen Receptor, miR-185, miR-205, and miR-21 in Breast Cancer Subtypes
por: Kalinina, Tatiana S., et al.
Publicado: (2020) -
Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas
por: Dusílková, Nina, et al.
Publicado: (2017) -
Interactive role of miR‐29, miR‐93, miR‐205, and VEGF in salivary adenoid cystic carcinoma
por: Bayat, Parisa, et al.
Publicado: (2022) -
MiR-205 and MiR-373 Are Associated with Aggressive Human Mucinous Colorectal Cancer
por: Eyking, Annette, et al.
Publicado: (2016)